The global eubiotics market size is expected to reach USD 10.89 Billion in 2028 and register a CAGR of 8.0% over the forecast period, according to latest analysis by Emergen Research. Key factors projected to drive market revenue growth include increasing global consumption of meat, specifically chicken, milk, and eggs owing to a rapidly growing global population, shift in dietary preferences, changing food consumption patterns, rising demand for manufactured feed, and increasing awareness about feed quality on livestock health and wellness.
In addition, increasing incidence of poultry disease outbreaks have resulted in more stringent regulations and norms being implemented by governments, which is a factor prompting livestock farmers to increase focus on livestock health and shift towards more healthy feeds and additives. Use of traditional antibiotic growth promoters in animal farming has been banned in various countries as it posed health challenges over the years. The ban has resulted in a rapid shift towards eubiotics as an alternative to antibiotics. Manufacturers have introduced targeted solutions to boost the immunity of livestock against bacterial and viral infections, enhance lactose tolerance levels, and improve digestive efficacy.
Get a sample of the report @ https://www.emergenresearch.com/industry-report/eubiotics-market
Overview of the TOC of the Report:
Market Dynamics:
The report offers insightful information about the market dynamics of the Eubiotics market. It offers SWOT analysis, PESTEL analysis, and Porter’s Five Forces analysis to present a better understanding of the Eubiotics market, competitive landscape, factors affecting it, and to predict the growth of the industry. It also offers the impact of various market factors along with the effects of the regulatory framework on the growth of the Eubiotics market.
Key players in the global eubiotics market are BASF SE, Novus International, Lallemand Inc., Cargill Inc., Koninklijke DSM NV, Kemin Industries, Lesaffre Group, Behn Mayer Group, Yara International ASA, and DuPont.
The complete regional analysis covers:
Emergen Research has segmented the eubiotics market on the basis of product, form, application, end-use, and region:
Product Outlook (Revenue, USD Billion; 2018–2028)
Form Outlook (Revenue, USD Billion; 2018-2028)
Application Outlook (Revenue, USD Billion; 2018-2028)
End-use Outlook (Revenue, USD Billion; 2018–2028)
Key points of Eubiotics Market:
Take a Look at our Related Reports:
surgical robotics market
https://www.google.bj/url?q=https://www.emergenresearch.com/industry-report/surgical-robotics-market
continuous glucose monitoring system market
phototherapy devices market
sensor fusion market
https://www.google.bj/url?q=https://www.emergenresearch.com/industry-report/sensor-fusion-market
interventional cardiology market
nanofilms market
https://www.google.bj/url?q=https://www.emergenresearch.com/industry-report/nanofilms-market
breath analyzers market
https://www.google.bj/url?q=https://www.emergenresearch.com/industry-report/breath-analyzers-market
alopecia market
https://www.google.bj/url?q=https://www.emergenresearch.com/industry-report/alopecia-market
power to gas market
https://www.google.bj/url?q=https://www.emergenresearch.com/industry-report/power-to-gas-market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services